<DOC>
	<DOCNO>NCT02714790</DOCNO>
	<brief_summary>Study purpose assess prognostic role Minimal Residual Disease ( define medullary expression WT1 gene ) , perform Baseline treatment accord clinical practice . MRD result relate treatment outcome survival analysis variable ( Overall Survival , Disease Free Survival , Cumulative Incidence Relapse )</brief_summary>
	<brief_title>Prognostic Role Minimal Residual Disease Acute Myeloid Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Neoplasm , Residual</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<criteria>Diagnosis Acute Myeloid Leukemia Age &gt; 18 year Intensive chemotherapy first line curative treatment Observation period : March 2004 September 2014 Bone marrow WT1 expression Immunophenotyping multiparametric flow cytometry perform baseline Written inform consent Diagnosis Acute Promyelocytic Leukemia Bone marrow WT1 expression Immunophenotyping multiparametric flow cytometry NOT perform baseline Patient ineligible intensive chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Acute Myeloid Leukemia</keyword>
	<keyword>Minimal Residual Disease</keyword>
	<keyword>Wilms Tumor</keyword>
</DOC>